logo-loader
viewMerck & Co., Inc.

Merck Head of Pacific BD&L sees a 'coming of age' in how the immune system plays role in neuroscience

Merck & Co (NYSE:MRK) Head of Pacific Business Development & Licensing Hub and President of the MRL Ventures Fund Reza Halse sat down with Proactive at the BIO Investor Forum in San Francisco. 

Halse says he's seeing a 'coming of age' in neuroscience, especially seeing an increased understanding of the immune system's role in neurodegenerative disorder.

Quick facts: Merck & Co., Inc.

Price: 79.04 USD

NYSE:MRK
Market: NYSE
Market Cap: $199.5 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

ioneer Ltd's Bernard Rowe hails new boric acid distribution and sales agreements

ioneer Ltd's (ASX:INR) Bernard Rowe speaks to Proactive's Andrew Scott after securing two distribution and sales agreements for the supply of boric acid from its Rhyolite Ridge Lithium-Boron Project in Nevada, USA. The three-year boric acid distribution and sales agreements were signed with...

3 hours, 57 minutes ago

2 min read